Breaking News, Collaborations & Alliances

SpectronRx, RLS Partner to Boost Radiopharmaceutical Pipeline and Supply Chain

Marks latest step in RLS expansion into oncology and work to create unbroken chain of patient care from clinical trial to commercial supply.

SpectronRx, a radiopharmaceutical developer and manufacturer, and RLS (Radioisotope Life Sciences) Inc., a nuclear medicine pharmacy network, entered an agreement designed to enhance the supply and availability of diagnostic and therapeutic radiopharmaceuticals. The companies aim to further bridge the gap between drug development, manufacturing, distribution, and patient care by improving production and increasing the availability of medicines.  As part of the agreement, SpectronRx will manuf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters